128 related articles for article (PubMed ID: 34668377)
1. Magnetic Resonance Imaging-Guided Multi-Stimulus-Responsive Drug Delivery Strategy for Personalized and Precise Cancer Treatment.
Liu C; Chen H; Zhou H; Yu S; Wang N; Yao W; Lu AH; Qiao W
ACS Appl Mater Interfaces; 2021 Nov; 13(43):50716-50732. PubMed ID: 34668377
[TBL] [Abstract][Full Text] [Related]
2. Sensitive and precise visually guided drug delivery nanoplatform with dual activation of pH and light.
Liu C; Zhou H; Yu S; Chen H; Wang N; Yao W; Lu AH; Qiao W
Acta Biomater; 2022 Mar; 141():374-387. PubMed ID: 34971788
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
4. Series of High Magnetic Resonance-Guided Photoinduced Nanodelivery Systems for Precisely Improving the Efficiency of Cancer Therapy.
Liu C; Yao W; Zhou H; Chen H; Yu S; Qiao W
ACS Appl Mater Interfaces; 2022 May; 14(18):20616-20627. PubMed ID: 35471860
[TBL] [Abstract][Full Text] [Related]
5. A Multifunctional Lipid Incorporating Active Targeting and Dual-Control Release Capabilities for Precision Drug Delivery.
Liu C; Ewert KK; Yao W; Wang N; Li Y; Safinya CR; Qiao W
ACS Appl Mater Interfaces; 2020 Jan; 12(1):70-85. PubMed ID: 31774266
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance activatable thermosensitive liposomes for controlled doxorubicin delivery.
Alawak M; Mahmoud G; Dayyih AA; Duse L; Pinnapireddy SR; Engelhardt K; Awak I; Wölk C; König AM; Brüßler J; Bakowsky U
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111116. PubMed ID: 32600717
[TBL] [Abstract][Full Text] [Related]
7. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
8. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
[TBL] [Abstract][Full Text] [Related]
9. A multifunctional lipid that forms contrast-agent liposomes with dual-control release capabilities for precise MRI-guided drug delivery.
Liu C; Ewert KK; Wang N; Li Y; Safinya CR; Qiao W
Biomaterials; 2019 Nov; 221():119412. PubMed ID: 31419656
[TBL] [Abstract][Full Text] [Related]
10. Intracellular delivery of drugs by chitosan-based multi-liposomal complexes.
Grozdova I; Melik-Nubarov N; Efimova A; Ezhov A; Krivtsov G; Litmanovich E; Yaroslavov A
Colloids Surf B Biointerfaces; 2020 Sep; 193():111062. PubMed ID: 32388392
[TBL] [Abstract][Full Text] [Related]
11. Targeted magnetic liposomes loaded with doxorubicin.
Pradhan P; Banerjee R; Bahadur D; Koch C; Mykhaylyk O; Plank C
Methods Mol Biol; 2010; 605():279-93. PubMed ID: 20072888
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
13. Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug.
Ling L; Ismail M; Du Y; Yao C; Li X
Int J Pharm; 2019 Apr; 560():246-260. PubMed ID: 30769133
[TBL] [Abstract][Full Text] [Related]
14. Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo.
Nguyen VD; Min HK; Kim CS; Han J; Park JO; Choi E
Colloids Surf B Biointerfaces; 2019 Jan; 173():539-548. PubMed ID: 30343218
[TBL] [Abstract][Full Text] [Related]
15. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-dCas9-Guided and Telomerase-Responsive Nanosystem for Precise Anti-Cancer Drug Delivery.
Ma Y; Mao G; Wu G; Cui Z; Zhang XE; Huang W
ACS Appl Mater Interfaces; 2021 Feb; 13(7):7890-7896. PubMed ID: 33513005
[TBL] [Abstract][Full Text] [Related]
17. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
[TBL] [Abstract][Full Text] [Related]
18. Precise delivery of multi-stimulus-responsive nanocarriers based on interchangeable visual guidance.
Liu CY; Chen HL; Zhou HJ; Yu SM; Yao WH; Wang N; Lu AH; Qiao WH
Biomater Adv; 2022 Mar; 134():112558. PubMed ID: 35525754
[TBL] [Abstract][Full Text] [Related]
19. Analyzing Liposomal Drug Delivery Systems in Three-Dimensional Cell Culture Models Using MALDI Imaging Mass Spectrometry.
Lukowski JK; Weaver EM; Hummon AB
Anal Chem; 2017 Aug; 89(16):8453-8458. PubMed ID: 28731323
[TBL] [Abstract][Full Text] [Related]
20. Multi-stimuli responsive nanosystem modified by tumor-targeted carbon dots for chemophototherapy synergistic therapy.
Wang X; Li X; Mao Y; Wang D; Zhao Q; Wang S
J Colloid Interface Sci; 2019 Sep; 552():639-650. PubMed ID: 31173992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
